Results 61 to 70 of about 58,938 (145)

Long-term patiromer adherence and renin-angiotensin aldosterone system inhibitor utilization: A retrospective study. [PDF]

World J Nephrol
Kleinman N, Desai T, Thakar C.
europepmc   +1 more source

Sodium-Glucose Cotransporter 2 Inhibitors in Alport Syndrome: Emerging Clinical Evidence and Mechanistic Insights. [PDF]

Kidney360
Miyata KN, Miner JH.
europepmc   +1 more source

Aldosterone synthesis inhibitors in resistant hypertension: the BaxHTN trial. [PDF]

Eur Heart J Suppl
Gallo G, Volterrani M, Tocci G, Volpe M.
europepmc   +1 more source

Comprehensive Management of Hyperkalaemia in Patients with Chronic Kidney Disease and Cardiovascular Conditions: Expert Recommendations from Mexico. [PDF]

Card Fail Rev
Méndez-Durán A, Ivey-Miranda JB, Mendoza-Zavala GH, Álvarez-Sangabriel A, Sánchez-Guerrero DC, Díaz-García JD, Borges-Vela JA, Morales-Buenrostro LE, Quilantán-Rodríguez M, Ruíz-Mejía R, Chávez-Leal SA.   +10 more
europepmc   +1 more source

Causal Effects of Renin-Angiotensin-Aldosterone System Inhibition on Renal Function in Patients With Chronic Kidney Disease: A Quasi-Experimental Study. [PDF]

Clin Transl Sci
Oh TR, Park J, Choi HS, Rhee H, Kang G.
europepmc   +1 more source

Is Obesity a Major Driver of Primary Aldosteronism? [PDF]

JACC Basic Transl Sci
Hall JE, Omoto ACM, Hall ME.
europepmc   +1 more source

Design, synthesis and biological evaluation of renin inhibitors guided by simulated annealing of chemical potential simulations. [PDF]

Bioorg Med Chem, 2017
Cloudsdale IS, Dickson JK, Barta TE, Grella BS, Smith ED, Kulp JL, Guarnieri F, Kulp JL.   +7 more
europepmc   +1 more source

Balancing Blood Pressure Targets and Kidney Health: The Potential Risk of Kidney Disease Due to Concentric Arterial and Arteriolar Hypertrophy From Renin-Angiotensin-Aldosterone Inhibitors. [PDF]

Hypertension
de Almeida LF, Wenzel U, Danser AHJ, Lembo G, Sequeira-Lopez MLS, Gomez RA.   +5 more
europepmc   +1 more source